A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2002
12/24/2002	US6498173 Treatment of diseases based on acute or chronic obstruction of vessels and/or bronchi and/or inflammation
12/24/2002	US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002	US6498171 Hydroxyomeprazole compositions
12/24/2002	US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis
12/24/2002	US6498164 Such as 1,3-dibenzyl-5-(phenyl- or 2-thienyl-acetyl)barbi-turic acid; malignant hypercalcemia, osteolytic diseases such as paget's disease, osteoporosis, articular rheumatism occurring in knees, shoulders, joints
12/24/2002	US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system
12/24/2002	US6498158 Il-5 inhibiting 6-azauracil derivatives
12/24/2002	US6498156 Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use
12/24/2002	US6498152 Use of a farnesyl transferase inhibitor in the manufacture of a medicament for local administration to the vascular wall in the prevention of restenosis
12/24/2002	US6498151 Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
12/24/2002	US6498022 Isolated nucleic acid molecules encoding human carbonate transporter proteins, and uses thereof
12/24/2002	US6497887 Delivery system for topical application to skin comprising freeze-dried, partially crosslinked polymeric gel membrane containing hyaluronic acid as disrupting agent, which can be returned to dissolvable gel upon application of wetting agent
12/24/2002	US6497871 Polypeptide having anti-viral and anti-proliferative activity
12/24/2002	US6497869 Having a ph of 5.0 to 8.0, and a salt comprising sulfate ions; treatment of shipping fever, bovine mastitis
12/24/2002	US6497725 Differential treatment of prosthetic devices
12/24/2002	CA2252039C Isatin derivatives as acetylcholinesterase inhibitors and analgesics
12/24/2002	CA2150812C Catechol diethers as selective pde iv inhibitors
12/24/2002	CA2086264C Surface complexed lymphotoxin
12/24/2002	CA2054339C 3-amidoindolyl derivatives
12/22/2002	CA2390897A1 Method of improving hatchability of eggs
12/21/2002	CA2390966A1 Compound for the treatment of atherosclerotic-thrombotic pathological conditions
12/19/2002	WO2002101385A1 In vivo bioreactors
12/19/2002	WO2002101357A2 Molecular signatures of commonly fatal carcinomas
12/19/2002	WO2002101049A2 Interleukin-18 mutants, their production and use
12/19/2002	WO2002101046A1 Monoclonal antibody binding to mt4-mmp catalytic domain
12/19/2002	WO2002101005A2 A g-protein coupled receptor and uses therefor
12/19/2002	WO2002100898A2 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
12/19/2002	WO2002100890A2 Respiratory syncytial virus
12/19/2002	WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
12/19/2002	WO2002100879A1 Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
12/19/2002	WO2002100863A1 Corticotropin releasing factor antagonists
12/19/2002	WO2002100862A2 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
12/19/2002	WO2002100859A1 Pde iv inhibitors
12/19/2002	WO2002100858A2 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors
12/19/2002	WO2002100857A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
12/19/2002	WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002	WO2002100848A1 Novel phenylalkyl diamine and amide analogs
12/19/2002	WO2002100847A2 Factor xa inhibitor
12/19/2002	WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002	WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100843A1 Phenoxazine compounds, the compositions containing them and their medicinal uses
12/19/2002	WO2002100838A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002	WO2002100833A1 Rho KINASE INHIBITORS
12/19/2002	WO2002100830A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	WO2002100827A2 Method for increasing the survival of dopamine secreting cells
12/19/2002	WO2002100826A2 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002	WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/19/2002	WO2002100818A2 Aminediols as agents for the treatment of alzheimer's disease
12/19/2002	WO2002100486A1 Method and apparatus for treating uterine myoma
12/19/2002	WO2002100456A1 Using supercritical fluids to infuse therapeutic on a medical device
12/19/2002	WO2002100445A1 Treatment and composition for wound healing
12/19/2002	WO2002100444A1 Colloidal metal labelled microparticles, their production and use
12/19/2002	WO2002100441A2 Method for treatment of vascular regeneration
12/19/2002	WO2002100437A2 Ophthalmic compositions comprising hyaluronic acid
12/19/2002	WO2002100433A1 Medicinal compositions
12/19/2002	WO2002100427A1 Liver generation promoter
12/19/2002	WO2002100426A1 Bmp binding proteins for use in bone or cartilage regeneration
12/19/2002	WO2002100421A1 Low molecular weight components of cartilage, complexes of copper with amino acids or di-peptides; processes for preparation and therapeutic uses thereof
12/19/2002	WO2002100413A1 A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- [4-(2-{4-METHANE SULFONYL OXYPHENYL} ETHOXY) PHENYL] PROPANOIC ACID OR 3-{4-[2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL} -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA
12/19/2002	WO2002100410A1 Methods of treating alzheimer's disease
12/19/2002	WO2002100408A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
12/19/2002	WO2002100405A1 Isoquinoline inhibitors of p38
12/19/2002	WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	WO2002100400A1 Organic nitrate-based compounds for the treatment of vasculopathies
12/19/2002	WO2002100399A1 Macrocycles useful in the treatment of alzheimer's disease
12/19/2002	WO2002100392A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
12/19/2002	WO2002100387A1 Prevention of neovascularization of intervertebral discs and/or of tissues with local inflammation
12/19/2002	WO2002100353A2 Cd10-activated prodrug compounds
12/19/2002	WO2002100352A2 Nr2b receptor antagonists for the treatment or prevention of migraines
12/19/2002	WO2002100351A2 A method for treating inflammatory diseases by administering a ppar-delta agonist
12/19/2002	WO2002100348A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
12/19/2002	WO2002100347A2 Prodrugs of gaba analogs, compositions and uses thereof
12/19/2002	WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/19/2002	WO2002100335A2 Methods for improving cell line activity in immunoisolation devices
12/19/2002	WO2002100332A2 Isoxazoline compounds having mif antagonist activity
12/19/2002	WO2002100328A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002	WO2002100309A1 Quinolone carboxylic acid compositions and related methods of treatment
12/19/2002	WO2002100193A1 Body temperature-raising agent of amino acids for eating or drinking and for medical use
12/19/2002	WO2002092606A8 Fused imidazolidine derivatives, process for preparation of the same and use thereof
12/19/2002	WO2002088144A3 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO[2,3-f]QUINOXALINE
12/19/2002	WO2002087604A3 Preparations containing a combination of vitamin e and afamin
12/19/2002	WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002	WO2002085853A3 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/19/2002	WO2002081677A3 Improved gene expression
12/19/2002	WO2002076388A3 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
12/19/2002	WO2002074243A3 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
12/19/2002	WO2002074236A3 Skin whiteners containing hydroxytetronic acid
12/19/2002	WO2002072544A3 Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof
12/19/2002	WO2002070565A3 High-affinity antagonists of elr-cxc chemokines
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070541A3 Peptide deformylase inhibitors
12/19/2002	WO2002070515A3 Chromane derivatives, process for their preparation and their use as antitumor agents
12/19/2002	WO2002064755A3 Post-partum mammalian placenta, its use and placental stem cells therefrom
12/19/2002	WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002	WO2002060421A3 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence
12/19/2002	WO2002059080A3 Trisubstituted carbocyclic cyclophilin binding compounds and their use

1 ... 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 ... 1564